| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
1 company
Rodman David Malcom serves as a Chief Medical Officer at MLYS. Across recent SEC filings that breaks down to 0 buys and 41 sells. Those positions are worth an estimated $1.4M at current prices.
Historically, Rodman David Malcom's trades have earned a middling insider score of 54/100 across 26 rated trades. Over a 12-month horizon, 27.3% of those trades were profitable, with an average 12-month return of -52.7%.
The biggest single holding is MLYS (~$1.4M) as Chief Medical Officer. The recent filings there lean toward selling, a net 770,567 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 10, 2026 | MLYS Mineralys Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 2,170 | $27.09 | $58,785.30 | -4.1% | - | - | |
| Jul 17, 2026 | MLYS Mineralys Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 416 | $26.53 | $11,036.48 | -0.8% | - | - | |
| Jul 15, 2026 | MLYS Mineralys Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 20,407 | $27.28 | $556,671.34 | -15.8% | - | - | |
| Jul 9, 2026 | MLYS Mineralys Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 2,171 | $30.30 | $65,781.30 | -3.6% | - | - | |
| Jun 17, 2026 | MLYS Mineralys Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 14,474 | $24.19 | $350,086.83 | -11.2% | - | - | |
| Apr 17, 2026 | MLYS Mineralys Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 416 | $31.33 | $13,033.28 | -0.6% | -11.4% | - | |
| Apr 15, 2026 | MLYS Mineralys Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 20,406 | $26.89 | $548,672.35 | -12.3% | -10.3% | - | |
| Apr 9, 2026 | MLYS Mineralys Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 2,170 | $27.38 | $59,414.60 | -2.8% | +11.9% | - | |
| Mar 13, 2026 | MLYS Mineralys Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 20,406 | $26.61 | $542,973.39 | -6.1% | -8.6% | - | |
| Jan 14, 2026 | MLYS Mineralys Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 19,076 | $32.66 | $623,114.66 | -14.5% | -20.3% | - |